Published in J Cell Biol on November 17, 1997
Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming beta cell function in humans. Nat Med (2011) 1.62
New roles of carboxypeptidase E in endocrine and neural function and cancer. Endocr Rev (2012) 1.23
TRPM7 facilitates cholinergic vesicle fusion with the plasma membrane. Proc Natl Acad Sci U S A (2008) 1.17
An acidic motif retains vesicular monoamine transporter 2 on large dense core vesicles. J Cell Biol (2001) 1.07
Regulation of large dense-core vesicle volume and neurotransmitter content mediated by adaptor protein 3. Proc Natl Acad Sci U S A (2006) 1.06
A phosphorylation site regulates sorting of the vesicular acetylcholine transporter to dense core vesicles. J Cell Biol (2000) 1.05
Projections from the rat pedunculopontine and laterodorsal tegmental nuclei to the anterior thalamus and ventral tegmental area arise from largely separate populations of neurons. Brain Struct Funct (2011) 1.00
Trafficking of vesicular neurotransmitter transporters. Traffic (2008) 0.99
Non-neuronal cholinergic machinery present in cardiomyocytes offsets hypertrophic signals. J Mol Cell Cardiol (2012) 0.95
Storage and secretion of beta-NAD, ATP and dopamine in NGF-differentiated rat pheochromocytoma PC12 cells. Eur J Neurosci (2009) 0.92
A distinct trans-Golgi network subcompartment for sorting of synaptic and granule proteins in neurons and neuroendocrine cells. J Cell Sci (2011) 0.85
Search for the acetylcholine and vesamicol binding sites in vesicular acetylcholine transporter: the region around the lumenal end of the transport channel. J Neurochem (2010) 0.82
A tyrosine-based motif localizes a Drosophila vesicular transporter to synaptic vesicles in vivo. J Biol Chem (2010) 0.80
Uncovering genes required for neuronal morphology by morphology-based gene trap screening with a revertible retrovirus vector. FASEB J (2012) 0.80
Signals involved in targeting membrane proteins to synaptic vesicles. Cell Mol Neurobiol (2002) 0.79
Varicones and growth cones: two neurite terminals in PC12 cells. PLoS One (2009) 0.78
Age-related attenuation of parasympathetic control of the heart in mice. Int J Physiol Pathophysiol Pharmacol (2015) 0.77
Retrograde trafficking of VMAT2 and its role in protein stability in non-neuronal cells. J Biomed Res (2016) 0.75
Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A (1976) 21.06
Interaction of tyrosine-based sorting signals with clathrin-associated proteins. Science (1995) 7.77
NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor. J Biol Chem (1990) 5.91
Signal sequence recognition and protein targeting to the endoplasmic reticulum membrane. Annu Rev Cell Biol (1994) 5.54
Coatomer interaction with di-lysine endoplasmic reticulum retention motifs. Science (1994) 4.77
The synaptic vesicle cycle: a single vesicle budding step involving clathrin and dynamin. J Cell Biol (1996) 3.03
Colocalization of synaptophysin with transferrin receptors: implications for synaptic vesicle biogenesis. J Cell Biol (1991) 2.59
A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell (1992) 2.58
Clathrin-coated vesicular transport of secretory proteins during the formation of ACTH-containing secretory granules in AtT20 cells. J Cell Biol (1986) 2.40
The cytoplasmic tail of the mannose 6-phosphate/insulin-like growth factor-II receptor has two signals for lysosomal enzyme sorting in the Golgi. J Cell Biol (1992) 2.32
The Caenorhabditis elegans unc-17 gene: a putative vesicular acetylcholine transporter. Science (1993) 2.26
Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport. Physiol Rev (1988) 2.14
Pathways to regulated exocytosis in neurons. Annu Rev Physiol (1990) 2.13
Glutamate uptake by brain synaptic vesicles. Energy dependence of transport and functional reconstitution in proteoliposomes. J Biol Chem (1988) 2.03
Biogenesis of synaptic vesicle-like structures in a pheochromocytoma cell line PC-12. J Cell Biol (1990) 2.03
Membrane fusion machinery: insights from synaptic proteins. Cell (1993) 1.96
Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc Natl Acad Sci U S A (1992) 1.95
Vesicular neurotransmitter transporters: from bacteria to humans. Physiol Rev (1995) 1.78
Synaptophysin is targeted to similar microvesicles in CHO and PC12 cells. EMBO J (1989) 1.75
Differential expression of two vesicular monoamine transporters. J Neurosci (1995) 1.75
Synaptic vesicle biogenesis, docking, and fusion: a molecular description. Physiol Rev (1996) 1.65
Intracellular transport and packaging of prolactin: a quantitative electron microscope autoradiographic study of mammotrophs dissociated from rat pituitaries. Endocrinology (1978) 1.64
Newly synthesized synaptophysin is transported to synaptic-like microvesicles via constitutive secretory vesicles and the plasma membrane. EMBO J (1991) 1.63
Synthesis, storage and release of acetylcholine by a noradrenergic pheochromocytoma cell line. Nature (1977) 1.58
The AP-1 adaptor complex binds to immature secretory granules from PC12 cells, and is regulated by ADP-ribosylation factor. J Cell Biol (1996) 1.55
Functional identification of a vesicular acetylcholine transporter and its expression from a "cholinergic" gene locus. J Biol Chem (1994) 1.54
Clathrin-immunoreactive sites in the Golgi apparatus are concentrated at the trans pole in polypeptide hormone-secreting cells. Proc Natl Acad Sci U S A (1985) 1.54
Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat. J Mol Neurosci (1994) 1.54
Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine. J Neurosci (1996) 1.52
Cytoplasmic domain of P-selectin (CD62) contains the signal for sorting into the regulated secretory pathway. Mol Biol Cell (1992) 1.48
Storage and release of neurotransmitters. Cell (1993) 1.48
Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles. Proc Natl Acad Sci U S A (1996) 1.45
Protein targeting via the "constitutive-like" secretory pathway in isolated pancreatic islets: passive sorting in the immature granule compartment. J Cell Biol (1992) 1.41
Selective storage of acetylcholine, but not catecholamines, in neuroendocrine synaptic-like microvesicles of early endosomal origin. Neuron (1993) 1.40
Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles. J Neurosci (1996) 1.36
Secretory granule and synaptic vesicle formation. Curr Opin Cell Biol (1991) 1.33
A biosynthetic regulated secretory pathway in constitutive secretory cells. J Cell Biol (1996) 1.31
Energy dependence and functional reconstitution of the gamma-aminobutyric acid carrier from synaptic vesicles. J Biol Chem (1990) 1.25
P-selectin, a granule membrane protein of platelets and endothelial cells, follows the regulated secretory pathway in AtT-20 cells. J Cell Biol (1992) 1.25
Distinct molecular mechanisms for protein sorting within immature secretory granules of pancreatic beta-cells. J Cell Biol (1994) 1.23
Gene transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4-phenylpyridinium. Proc Natl Acad Sci U S A (1992) 1.23
Molecular cloning of a putative vesicular transporter for acetylcholine. Proc Natl Acad Sci U S A (1994) 1.18
Storage and release of acetylcholine by a clonal cell line. Proc Natl Acad Sci U S A (1977) 1.16
The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei. Proc Natl Acad Sci U S A (1995) 1.11
Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells. J Cell Biol (1994) 1.10
Neurotransmission: harnessing fusion machinery at the synapse. Trends Neurosci (1994) 1.07
Acetylcholine transport, storage, and release. Int Rev Neurobiol (1993) 1.06
Active transport of gamma-aminobutyric acid and glycine into synaptic vesicles. Proc Natl Acad Sci U S A (1989) 1.01
Proton gradient linkage to active uptake of [3H]acetylcholine by Torpedo electric organ synaptic vesicles. Biochemistry (1982) 1.00
Exocytosis from large and small dense cored vesicles in noradrenergic nerve terminals. Neuroscience (1983) 0.96
The polymeric immunoglobulin receptor accumulates in specialized endosomes but not synaptic vesicles within the neurites of transfected neuroendocrine PC12 cells. J Cell Biol (1994) 0.95
The transport of neurotransmitters into synaptic vesicles. Curr Opin Neurobiol (1992) 0.93
Neural degeneration and the transport of neurotransmitters. Ann Neurol (1993) 0.91
Biochemical evidence that vesicles are the source of the acetylcholine released from stimulated PC12 cells. Proc Natl Acad Sci U S A (1984) 0.91
The molecular machinery for fast and slow neurosecretion. Curr Opin Neurobiol (1994) 0.88
A unique gene organization for two cholinergic markers, choline acetyltransferase and a putative vesicular transporter of acetylcholine. J Biol Chem (1994) 0.88
Active transport of acetylcholine by the human vesicular acetylcholine transporter. J Biol Chem (1996) 0.87
Choline and acetylcholine metabolism in PC12 secretory cells. Biochemistry (1981) 0.82
Vesamicol binding to subcellular membranes that are distinct from catecholaminergic vesicles in PC12 cells. J Neurochem (1992) 0.78
A report--chronic fatigue syndrome: guidelines for research. J R Soc Med (1991) 7.70
The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron (2001) 4.97
Human skeletal muscle function: description of tests and normal values. Clin Sci Mol Med (1977) 4.71
Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. Proc Natl Acad Sci U S A (1994) 4.67
Predicted normal values for maximal respiratory pressures in caucasian adults and children. Thorax (1984) 4.42
Identification and characterization of the vesicular GABA transporter. Nature (1997) 4.26
An increasing work rate test for assessing the physiological strain of submaximal exercise. Clin Sci Mol Med (1974) 3.73
Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. Science (2000) 3.68
Implications of socio-cultural contexts for the ethics of clinical trials. Health Technol Assess (1997) 3.57
Cloning of a delta opioid receptor by functional expression. Science (1992) 3.49
An analysis of the physiological strain of submaximal exercise in patients with chronic obstructive bronchitis. Thorax (1975) 3.13
Fatigue of long duration in human skeletal muscle after exercise. J Physiol (1977) 2.98
Ultrastructural changes after concentric and eccentric contractions of human muscle. J Neurol Sci (1983) 2.86
The vesicular GABA transporter, VGAT, localizes to synaptic vesicles in sets of glycinergic as well as GABAergic neurons. J Neurosci (1998) 2.76
A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell (1992) 2.58
Muscle protein synthesis measured by stable isotope techniques in man: the effects of feeding and fasting. Clin Sci (Lond) (1982) 2.53
Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc Natl Acad Sci U S A (1998) 2.49
Normal muscle strength and fatigability in patients with effort syndromes. BMJ (1988) 2.46
bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci U S A (1993) 2.39
Expression of a putative vesicular acetylcholine transporter facilitates quantal transmitter packaging. Neuron (1997) 2.37
The synaptic vesicle protein SV2 is a novel type of transmembrane transporter. Cell (1992) 2.25
Pain and fatigue after concentric and eccentric muscle contractions. Clin Sci (Lond) (1983) 2.24
Implantation metastasis as a cause of local recurrence of colorectal carcinoma. Am J Surg (1989) 2.11
Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes. Nat Genet (2001) 2.07
Clinical use of nuclear magnetic resonance in the investigation of myopathy. Lancet (1982) 2.02
Metabolic changes associated with the slowing of relaxation in fatigued mouse muscle. J Physiol (1975) 1.95
Exertion of stairclimbing in normal subjects and in patients with chronic obstructive bronchitis. Thorax (1977) 1.92
Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron (1997) 1.83
Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome. BMJ (2001) 1.82
Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size. J Neurosci (2000) 1.81
Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proc Natl Acad Sci U S A (2000) 1.81
Molecular analysis of system N suggests novel physiological roles in nitrogen metabolism and synaptic transmission. Cell (1999) 1.79
The time course of phosphorylcreatine resynthesis during recovery of the quadriceps muscle in man. Pflugers Arch (1976) 1.78
Large delayed plasma creatine kinase changes after stepping exercise. Muscle Nerve (1983) 1.76
Differential expression of two vesicular monoamine transporters. J Neurosci (1995) 1.75
Central and peripheral fatigue in sustained maximum voluntary contractions of human quadriceps muscle. Clin Sci Mol Med (1978) 1.74
Practical problems in the respiratory care of patients with muscular dystrophy. N Engl J Med (1987) 1.74
Percutaneous needle-biopsy of skeletal muscle in diagnosis and research. Lancet (1971) 1.72
Conchotome and needle percutaneous biopsy of skeletal muscle. J Neurol Neurosurg Psychiatry (1987) 1.72
Effect of temperature on muscle energy metabolism and endurance during successive isometric contractions, sustained to fatigue, of the quadriceps muscle in man. J Physiol (1972) 1.68
Excitation frequency and muscle fatigue: mechanical responses during voluntary and stimulated contractions. Exp Neurol (1979) 1.68
Sequence variation in the Epstein-Barr virus latent membrane protein 1. J Gen Virol (1994) 1.67
Repeatability of physical signs in airways obstruction. Thorax (1969) 1.65
Hypoxemia during sleep in Duchenne muscular dystrophy. Am Rev Respir Dis (1988) 1.63
The localization of the brain-specific inorganic phosphate transporter suggests a specific presynaptic role in glutamatergic transmission. J Neurosci (1998) 1.58
Nocturnal oxygenation and prognosis in Duchenne muscular dystrophy. Am J Respir Crit Care Med (1999) 1.54
Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine. J Neurosci (1996) 1.52
Transient developmental expression of monoamine transporters in the rodent forebrain. J Comp Neurol (1998) 1.48
Electron spin resonance studies of intact mammalian skeletal muscle. Biochim Biophys Acta (1985) 1.48
Myositis ossificans non-progressiva--reversible muscle calcification in polymyositis. Br J Rheumatol (1989) 1.47
Exercise performance and fatiguability in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry (1993) 1.45
Hand-held dynamometer for evaluating voluntary-muscle function. Lancet (1974) 1.44
Intravenous magnesium loading in chronic fatigue syndrome. Lancet (1992) 1.44
The gating of nucleotide-sensitive K+ channels in insulin-secreting cells can be modulated by changes in the ratio ATP4-/ADP3- and by nonhydrolyzable derivatives of both ATP and ADP. J Membr Biol (1988) 1.44
The role of vesicular transport proteins in synaptic transmission and neural degeneration. Annu Rev Neurosci (1997) 1.42
Human muscle function and fatigue. Ciba Found Symp (1981) 1.41
Plasma creatine kinase changes after eccentric and concentric contractions. Muscle Nerve (1986) 1.40
Muscle strength and pre-osteomalacia in vegetarian Asian women. Lancet (1982) 1.39
Muscle relaxation rate, fibre-type composition and energy turnover in hyper- and hypo-thyroid patients. Clin Sci (Lond) (1979) 1.38
Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J Comp Neurol (1997) 1.38
Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles. J Neurosci (1996) 1.36
The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J Biol Chem (1994) 1.35
Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma. Proc Natl Acad Sci U S A (1996) 1.34
Physiological analysis of skeletal muscle weakness and fatigue. Clin Sci Mol Med (1978) 1.33
Exercise tolerance in chronic airway obstruction. Am Rev Respir Dis (1971) 1.33
Differential RNA splicing predicts two distinct nerve growth factor precursors. Nature (1986) 1.31
Heat production and chemical changes during isometric contractions of the human quadriceps muscle. J Physiol (1975) 1.30
Effect of exercise on protein turnover in man. Clin Sci (Lond) (1981) 1.29
Physiological correlates of perceived exertion in continuous and intermittent exercise with the same average power output. Eur J Clin Invest (1972) 1.28
The protooncogene bcl-2 inhibits apoptosis in PC12 cells. J Neurochem (1993) 1.28
Effects of Duchenne muscular dystrophy on muscle protein synthesis. Nature (1982) 1.28
31P-NMR studies of a human tumour in situ. Lancet (1983) 1.27
Muscle breakdown and repair in polymyositis: a case study. Muscle Nerve (1980) 1.27
Muscle fatigue and pain. Acta Med Scand Suppl (1986) 1.26
Protein synthesis in muscle measured in vivo in cachectic patients with cancer. Br Med J (Clin Res Ed) (1984) 1.26
Experimental mouse muscle damage: the importance of external calcium. Clin Sci (Lond) (1984) 1.26
Measurements of muscle strength and performance in children with normal and diseased muscle. Arch Dis Child (1976) 1.26
Amino acid transport system A resembles system N in sequence but differs in mechanism. Proc Natl Acad Sci U S A (2000) 1.26
Improving outpatient clinic efficiency using computer simulation. Int J Health Care Qual Assur Inc Leadersh Health Serv (1997) 1.26
Needle biopsy for muscle chemistry. Lancet (1975) 1.25
Objective quantification of muscle and fat in human dystrophic muscle by magnetic resonance image analysis. Muscle Nerve (1996) 1.25
Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy. Am J Respir Crit Care Med (2001) 1.24
Occult ischaemic necrosis of skeletal muscle associated with renal failure. BMJ (1990) 1.24
Gene transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4-phenylpyridinium. Proc Natl Acad Sci U S A (1992) 1.23
Size and composition of the calf and quadriceps muscles in Duchenne muscular dystrophy. A tomographic and histochemical study. J Neurol Sci (1983) 1.23
Effects of propranolol on response to exercise in hypertrophic obstructive cardiomyopathy. Br Heart J (1970) 1.23
Experimental skeletal muscle damage: the nature of the calcium-activated degenerative processes. Eur J Clin Invest (1984) 1.22
The outpatient experience: results of a patient feedback survey. Int J Health Care Qual Assur Inc Leadersh Health Serv (1998) 1.19
A flexible microprocessor system for the measurement of cell size. J Clin Pathol (1982) 1.18
Molecular cloning of a putative vesicular transporter for acetylcholine. Proc Natl Acad Sci U S A (1994) 1.18
How does dystrophin deficiency lead to muscle degeneration?--evidence from the mdx mouse. Neuromuscul Disord (1995) 1.18
Sternomastoid muscle function and fatigue in man. Clin Sci (Lond) (1980) 1.17
Inhibition of Ca2+-induced cytosolic enzyme efflux from skeletal muscle by vitamin E and related compounds. Biochem J (1989) 1.17
LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice. Oncogene (2006) 1.17
Fatigue in human metabolic myopathy. Ciba Found Symp (1981) 1.16
A comparative psychiatric assessment of patients with chronic fatigue syndrome and muscle disease. Psychol Med (1991) 1.15
Relaxation rate of constituent muscle-fibre types in human quadriceps. Clin Sci (Lond) (1979) 1.14
Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China. Int J Cancer (1998) 1.14
A leucine-based motif mediates the endocytosis of vesicular monoamine and acetylcholine transporters. J Biol Chem (1998) 1.13
The effect of temperature, ischaemia and contractile activity on the relaxation rate of human muscle. Clin Physiol (1982) 1.12